Search research articles
Contact Us
Filters
Showing results (311-320 of 420) with videos related to
Page
of 42
Sort By:
Diagnostic Microbiology and Infectious Disease
|
August 18, 2005
Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates
Thomas R Fritsche, Patty A Strabala, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
January 21, 2006
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004)
Lalitagauri M Deshpande, Helio S Sader, Eugenio Debbia, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2012
Linezolid surveillance results for the United States: LEADER surveillance program 2011
Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
December 6, 2016
Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate
Michael A Pfaller, Rodrigo E Mendes, Robert K Flamm, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013)
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2014
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
February 9, 2010
Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008)
Ana C Gales, Helio S Sader, Julival Ribeiro, et al.
The Journal of Antimicrobial Chemotherapy
|
July 9, 2018
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16
Michael A Pfaller, Rodrigo E Mendes, Leonard R Duncan, et al.
Diagnostic Microbiology and Infectious Disease
|
March 3, 2009
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents
Rodrigo E Mendes, Paul R Rhomberg, Jan M Bell, et al.
Antimicrobial Agents and Chemotherapy
|
February 10, 2016
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014
Helio S Sader, Robert K Flamm, Rodrigo E Mendes, et al.
Page
of 42
Search research articles
Search
Showing results (311-320 of 420) with videos related to
Sort By:
Page
of 42
Diagnostic Microbiology and Infectious Disease
|
August 18, 2005
Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates
Thomas R Fritsche, Patty A Strabala, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
January 21, 2006
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004)
Lalitagauri M Deshpande, Helio S Sader, Eugenio Debbia, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2012
Linezolid surveillance results for the United States: LEADER surveillance program 2011
Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
December 6, 2016
Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate
Michael A Pfaller, Rodrigo E Mendes, Robert K Flamm, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013)
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2014
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
February 9, 2010
Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008)
Ana C Gales, Helio S Sader, Julival Ribeiro, et al.
The Journal of Antimicrobial Chemotherapy
|
July 9, 2018
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16
Michael A Pfaller, Rodrigo E Mendes, Leonard R Duncan, et al.
Diagnostic Microbiology and Infectious Disease
|
March 3, 2009
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents
Rodrigo E Mendes, Paul R Rhomberg, Jan M Bell, et al.
Antimicrobial Agents and Chemotherapy
|
February 10, 2016
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014
Helio S Sader, Robert K Flamm, Rodrigo E Mendes, et al.
Page
of 42